OEM News

CVRx Launches New Barostim Programmer

Builds upon the earlier model and includes significant enhancements to both hardware and software.

CVRx Inc. has launched its new Barostim Programmer, which was approved by the U.S. Food and Drug Administration (FDA) in April.
 
The second-generation programmer has a modernized design, operates on an upgraded cellular network that enables remote view access, and includes an improved user interface that simplifies implantable pulse generator (IPG) programming. Furthermore, the new Barostim Programmer is compatible with all Barostim implantable systems.
 
“The new Barostim Programmer builds upon the earlier model and includes significant enhancements to both hardware and software,” said Nadim Yared, president and CEO of CVRx. “This upgrade allows CVRx to continue to provide superior customer support and reflects our commitment to innovating across all aspects of Barostim therapy.”
 
A complete rollout of the new Barostim Programmer is planned across the U.S. market throughout 2022.

Keep Up With Our Content. Subscribe To Medical Product Outsourcing Newsletters